The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same mRNA ...
An international team of researchers has developed an innovative strategy for producing new vaccines. They created a ...
The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results